Health tech is global business
Revenio’s market is global. Our R&D centers, centers of excellence, are located in Finland and Italy. The R&D of product related to Tonometry and is done in Finland and the R&D of optical products and software in Italy. Our objective is to expand our already established status through our global distributor network and our own, strong sales channels in the United States.
Health care facing unprecedented global challenges
- Population growth
- Aging population
- Inequality
- Chronic diseases become more common
- Infrastructures are incapable of treating the required numbers of patients
Need for cost-effective health care
The need of preventive health care is increasing.
Innovations that are easily available everywhere in the world increase quality and productivity of health care.
Too little screening is still performed, considering the benefits that could be reaped.
Leading products worldwide
Revenio is a leading player in ophthalmic products related to eye diagnostics. We offer our clients all the necessary modern products for the detection, diagnostics and monitoring of eye diseases. Our clear and strong R&D program for the future supports our goal to keep our position as the leading company in our field.
The R&D focused Revenio Research on the other hand focuses on the commercialization of systems that assist to plan the diagnosis and treatment of skin cancer and asthma.
The Icare ic100, Icare TA01i, and Icare HOME, suitable for self-monitoring, are quick, reliable, accurate, and easy-to-use tonometers for the diagnosis and monitoring of glaucoma. The use of the Icare tonometers does not require local anesthesia or expertise in ophthalmology.
Icare CLINIC cloud enables the storage of IOP information from the Icare HOME self-tonometer and the Icare ic200 tonometer safely and easily. Icare CLINIC provides tools for analysis and reporting of IOP data for improved glaucoma management. Care team members have access to patient information via PC or mobile device whenever needed.
The Icare TONOVET Plus tonometer for animals is the only product on the market the operation of which is based on clinical studies conducted on different species.
In April of 2019 Revenio acquired CenterVue. CenterVue develops, produces and sells high-technology optical diagnostics equipment for early detection of eye diseases and for their monitoring during the treatment process. These diseases include Glaucoma, Diabetic Retinopathy and Macular degeneration.
The hyperspectral camera Cutica® is an easy-to-use and portable device to be developed for dermatologists to detect skin cancers and their precursors and determine their borders.
The Ventica® system is designed to assist in the diagnosis of asthma and monitoring its control in children aged 1–5 years. The measurement is done easily at night, while the child is asleep at home. The analysis software examines the variability in tidal breathing and provides the physician with a simple, objective report to support clinical assessment.
Strategic strengths
Brand
A strong and valued brand
Production
Volume-flexible production model
Financial aspects
Profitability and balance sheet
Shareholder value
Expertise and people
Understanding of the industry and global markets
Distribution channels and a strong global presence
Products and processes of world-class quality
Technology
Research and development
A steady cash flow from probe sales
Utilization of IP-protected Finnish inventions